CoChat

Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis

Zelman, Diane C, Hoffman, Deborah L, Seifeldin, Raafat, Dukes, Ellen M · 2003 · Pain
Cited by 140

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The objective of this study was to adapt the concept of 'episode-free day', a metric for measuring symptom relief in daily units, to the clinical outcome literature for persistent pain. The episode-free day metric is widely used in other medical literature, but no analogous measure exists in pain literature. Prior focus groups with this population suggested that a 'Day of Manageable Pain Control' was an appropriate name for the metric. In the present study, in order to derive a statistical criterion for 'Manageable Day', we used Serlin et al.'s (Pain 61 (1995) 277) cut-point derivation method to derive a single cut-point on a 0-10 scale of average pain that divided groups with significant persistent pain optimally on pain-related functional interference. Participants were 194 patients with moderate-severe low back pain (n=96) or osteoarthritis (n=98). For both patient samples, '5' was the cut-point that optimally distinguished groups on pain-related interference. '5-8' and '5-7' were double cut-point solutions that optimally divided LBP and OA samples into three categories (e.g. lowest, medium and highest average pain), respectively. Derived cut-points were confirmed using a variety of measures of functional disability. Together with research that showed that average pain ratings of approximately 5 and below permit increased function and quality of life in patients with moderate to severe low back pain and osteoarthritis, our findings provide support for the use of 0-5 on a 0-10 numeric average pain severity scale as one possible criterion for a Manageable Day.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0304-3959(03)00274-4

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 12

  1. Bellamy, 1988, Validation study of WOMAC: A health status instrument for measuring clinically-important patient-relevant outcomes to antiarthritic drug therapy in patients with osteoarthritis of the hip or knee. J., Rheumatol, 15, 1833
  2. Cleeland, 1984, The impact of pain on the patient with cancer., Cancer, 54, 2635, 10.1002/1097-0142(19841201)54:2+<2635::AID-CNCR2820541407>3.0.CO;2-P · DOI · Paper page
  3. Jensen, 2001, Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate and severe pain., Pain, 91, 317, 10.1016/S0304-3959(00)00459-0 · DOI · Paper page
  4. Makarowski, 2002, Efficacy and safety of the COX-2 inhibitor valdexoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen., Osteoarthritis Cartilage, 10, 290, 10.1053/joca.2001.0510 · DOI
  5. Robinson, 1993, Cost-effectiveness analysis., Br Med J, 307, 793, 10.1136/bmj.307.6907.793 · DOI · Paper page
  6. Sculpher, 1993, The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy., Pharmacoeconomics, 5, 345, 10.2165/00019053-199304050-00005 · doi:10.2165/00019053-199304050-00005
  7. Serlin, 1995, When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function., Pain, 61, 277, 10.1016/0304-3959(94)00178-H · DOI · Paper page
  8. van den Boom, 2001, The cost effectiveness of early treatment with fluticasone propionate 250 micrograms twice a day in subjects with obstructive airway disease. Results of the DIMCA program., Am J Respir Crit Care Med, 164, 2057, 10.1164/ajrccm.164.11.2003151 · DOI
  9. Ware, 1992, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection., Med Care, 30, 473, 10.1097/00005650-199206000-00002 · DOI · Paper page
  10. Wolfe, 1999, Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia., Rheumatology, 38, 355, 10.1093/rheumatology/38.4.355 · DOI · Paper page
  11. Zelman, 2003, Quantifying a day of manageable pain control: The relationship between pain severity and patient daily functional expectations., J Pain, 4, 1, 10.1016/S1526-5900(03)00473-5 · doi:10.1016/s1526-5900(03)00473-5
  12. Zelman, 2003, A day of manageable pain control: daily pain relief goals of patients with persistent moderate to severe pain., J Pain, 4, 3

Cited by

See all 140

Metadata

Authors
Zelman, D. C., Hoffman, D. L., Seifeldin, R., & Dukes, E. M.
Venue
Pain
Published
2003-11
Volume
106
Issue
1
Pages
35-42
ISSN
0304-3959 (ISSN-L)
OpenAlex
W2092869308
Cited by
140
References
3
FWCI
3.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. https://app.cochat.ai/papers/10.1016/s0304-3959(03)00274-4
The paper
Zelman, D. C., Hoffman, D. L., Seifeldin, R., & Dukes, E. M. (2003). Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis. Pain. https://doi.org/10.1016/s0304-3959(03)00274-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.